DE60325657D1 - Formulierungen zur Behandlung von männlicher und weiblicher Impotenz - Google Patents

Formulierungen zur Behandlung von männlicher und weiblicher Impotenz

Info

Publication number
DE60325657D1
DE60325657D1 DE60325657T DE60325657T DE60325657D1 DE 60325657 D1 DE60325657 D1 DE 60325657D1 DE 60325657 T DE60325657 T DE 60325657T DE 60325657 T DE60325657 T DE 60325657T DE 60325657 D1 DE60325657 D1 DE 60325657D1
Authority
DE
Germany
Prior art keywords
male
treatment
formulations
female impotence
female
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325657T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Antonella Riva
Roberto Seghizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11449866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60325657(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of DE60325657D1 publication Critical patent/DE60325657D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE60325657T 2002-05-10 2003-04-30 Formulierungen zur Behandlung von männlicher und weiblicher Impotenz Expired - Lifetime DE60325657D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000990A ITMI20020990A1 (it) 2002-05-10 2002-05-10 Formulazioni utili nel trattamento dell'impotenza maschile e femminile

Publications (1)

Publication Number Publication Date
DE60325657D1 true DE60325657D1 (de) 2009-02-12

Family

ID=11449866

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60303925T Expired - Lifetime DE60303925T2 (de) 2002-05-10 2003-04-30 Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz
DE60325657T Expired - Lifetime DE60325657D1 (de) 2002-05-10 2003-04-30 Formulierungen zur Behandlung von männlicher und weiblicher Impotenz

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60303925T Expired - Lifetime DE60303925T2 (de) 2002-05-10 2003-04-30 Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz

Country Status (19)

Country Link
US (1) US7128932B2 (de)
EP (2) EP1658854B1 (de)
JP (1) JP4603351B2 (de)
KR (1) KR20040102212A (de)
CN (2) CN101164559A (de)
AT (2) ATE319466T1 (de)
AU (1) AU2003240478B8 (de)
CA (1) CA2485264A1 (de)
DE (2) DE60303925T2 (de)
DK (2) DK1503775T3 (de)
ES (2) ES2318406T3 (de)
HK (1) HK1085374A1 (de)
IL (2) IL165081A (de)
IT (1) ITMI20020990A1 (de)
NO (2) NO332805B1 (de)
PT (2) PT1503775E (de)
RU (2) RU2313357C2 (de)
SI (2) SI1503775T1 (de)
WO (1) WO2003094943A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6952691B2 (en) * 2002-02-01 2005-10-04 International Business Machines Corporation Method and system for searching a multi-lingual database
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
WO2006021930A2 (en) * 2004-08-25 2006-03-02 Femi-X A/S Aphrodisiac herbal composition for a female comprising epimedium grandiflorum, turnera diffusa var. aphrodisiaca, ilex paraguariensis and smilax spp
KR100660116B1 (ko) * 2005-01-26 2006-12-20 (주)포메디 홍삼 및 대두를 주성분으로 포함하는 복합 한방 제제를유효성분으로 함유하는 성기능 개선용 조성물
US20070042054A1 (en) * 2005-04-20 2007-02-22 Council Of Scientific And Industrial Research Functional aphrodisiac rolled herbal bidis and cigarettes
EP1932531A1 (de) * 2006-12-11 2008-06-18 Finzelberg GmbH & Co. KG Spezialextrakt und seine Verwendung zur Hemmung des Abbaus von cyclischem Guanosinmonophosphat (cGMP)
US8362088B2 (en) * 2006-12-14 2013-01-29 Warnock W Matthew Method and article of manufacture for encapsulating a homeopathic ingredient with a second ingredient
US9918489B2 (en) * 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
PT2477633E (pt) * 2009-09-17 2013-10-10 Tradapharma Sagl Suplemento dietético que estimula a função sexual masculina
ES2386859B1 (es) * 2011-02-07 2013-03-22 Eduardo Antonio Gómez De Diego Composición natural para aumentar el vigor.
RU2458537C1 (ru) * 2011-03-14 2012-08-20 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
ITLI20110007A1 (it) * 2011-09-10 2013-03-11 Lloyds Internat Credit Llc Una innovativa composizione naturale efficace per la cura dell'impotenza
TW201420745A (zh) * 2012-11-26 2014-06-01 Tian-De Li 擴充男性海綿體的複方精油
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
US10016477B1 (en) 2015-01-13 2018-07-10 Roger Yomba Ngue Natural composition
IT201700115753A1 (it) * 2017-10-13 2019-04-13 Cristalfarma S R L Integratore per attenuare i disturbi nella donna causati dall’invecchiamento
EP3560488A1 (de) * 2018-04-24 2019-10-30 Procare Health Iberia, S.L. Zusammensetzung zur behandlung weiblicher sexueller dysfunktion
WO2022027122A1 (en) * 2020-08-06 2022-02-10 Ramade & Cia Holding Corp. Compositions with cannabinoids of cannabis sativa for treating erectile and sexual dysfunction
IT202100031175A1 (it) * 2021-12-13 2023-06-13 Anvest Group S R L Composizione per il trattamento della disfunzione erettile
GR1010519B (el) * 2022-07-04 2023-08-10 Νικολαος Τυμπανιδης Καταπινομενο σκευασμα για τονωση της ζωτικοτητας, της αντοχης και της γενικοτερης ευεξιας των ανδρων

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084746A (zh) * 1992-11-25 1994-04-06 王立本 防治性病的特效壮阳药液及其制作方法
AU674602B2 (en) * 1993-09-14 1997-01-02 Hyung Ki Choi Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
CN1141185A (zh) * 1996-02-16 1997-01-29 范凯 保健药酒
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
DE69937564T2 (de) * 1998-08-03 2008-10-23 Ronald E. Sarasota Wheeler Prostata- formulierung
EP1183039A1 (de) * 1999-05-27 2002-03-06 Armadillo Pharmaceuticals, Inc. Pharmazeutische zubereitungen von aus natürlichen quellen extrahierten bioaktiven substanzen
RU2153347C1 (ru) 1999-06-04 2000-07-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения импотенции
US6803060B2 (en) * 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido
US6444237B1 (en) * 2001-09-13 2002-09-03 Pamela A. Heleen Herbal composition for enhancing sexual response
US20030068391A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H. Ingestible nerve and circulatory nutritional formulation

Also Published As

Publication number Publication date
ATE418995T1 (de) 2009-01-15
NO332805B1 (no) 2013-01-14
ES2259139T3 (es) 2006-09-16
NO20120620L (no) 2004-11-08
CN1652806A (zh) 2005-08-10
AU2003240478A1 (en) 2003-11-11
US20050220905A1 (en) 2005-10-06
PT1658854E (pt) 2009-03-23
EP1658854A3 (de) 2007-04-25
US7128932B2 (en) 2006-10-31
IL192138A0 (en) 2008-12-29
DE60303925T2 (de) 2006-08-24
EP1658854B1 (de) 2008-12-31
JP4603351B2 (ja) 2010-12-22
PL371674A1 (en) 2005-06-27
KR20040102212A (ko) 2004-12-03
NO20044855L (no) 2004-11-08
HK1085374A1 (en) 2006-08-25
SI1658854T1 (sl) 2009-04-30
RU2004132833A (ru) 2005-06-27
EP1503775A1 (de) 2005-02-09
DK1503775T3 (da) 2006-07-17
IL192138A (en) 2010-12-30
PT1503775E (pt) 2006-07-31
AU2003240478B2 (en) 2007-05-31
DE60303925D1 (de) 2006-05-04
DK1658854T3 (da) 2009-03-09
IL165081A0 (en) 2005-12-18
ES2318406T3 (es) 2009-05-01
ATE319466T1 (de) 2006-03-15
AU2003240478B8 (en) 2009-08-06
SI1503775T1 (sl) 2006-06-30
CN100356935C (zh) 2007-12-26
RU2440127C2 (ru) 2012-01-20
EP1503775B1 (de) 2006-03-08
CN101164559A (zh) 2008-04-23
RU2313357C2 (ru) 2007-12-27
ITMI20020990A1 (it) 2003-11-10
EP1658854A2 (de) 2006-05-24
RU2007108559A (ru) 2008-09-20
JP2005529915A (ja) 2005-10-06
ITMI20020990A0 (it) 2002-05-10
CA2485264A1 (en) 2003-11-20
WO2003094943A1 (en) 2003-11-20
IL165081A (en) 2009-09-22

Similar Documents

Publication Publication Date Title
HK1085374A1 (en) Formulations useful in the treatment of male and female impotence
DE60303940D1 (de) Formulierungen zur behandlung von männlicher und weiblicher impotenz
ME00520B (me) Levodop/karbidop/entakapon farmaceutski preparat
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
BRPI0408270A (pt) composição farmacêutica compreendendo ácido 5-metil-2-(2'cloro-6'-fluoroanilino)fenilacético
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
NO20061223L (no) Orale sammensetninger for behandlingen av cellulitt
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose
DE69918339D1 (de) Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz
ATE372771T1 (de) Verwendung von 1-thiadibenzo e,h azulenen zur herstellung von pharmazeutischen formulierungen für die behandlung und prävention von erkrankungen und störungen des zentralen nervensystems
ATE353221T1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
UA39044A (uk) Склад для лікування хвороб пародонта
GEU20041132Y (en) Means for Treatment of Oral Cavity Diseases.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8364 No opposition during term of opposition